Oxidative stress, nonenzymatic antioxidants and inflammation status at rest
| COPD | Control | |
| Subjects n | 10 | 7 |
| TBARs nM | 0.82±0.22 | 0.78±0.02 |
| AOPP µM chloramine‐T equivalents | 17.1±1.3 | 17.8±1.1 |
| Total antioxidant capacity mM | 1.43±0.03 | 1.46±0.03 |
| Vitamin E×103/(TG+CL) | 4.65±0.26 | 4.33±0.18 |
| Uric acid µM | 308±25.6 | 324±19.4 |
| Albumin g·L−1 | 45.1±0.85 | 48±1.47 |
| CRP mg·L−1 | 9.3±2.4* | 1.3±0.3 |
| TNF‐α pg·mL−1 | 1.82±0.15** | 0.92±0.16 |
| IL‐6 pg·mL−1 | 9.46±2.91* | 1.44±0.20 |
Data are presented as mean±sem
COPD: chronic obstructive pulmonary disease
TBARs: thiobarbituric acid reactive substances
AOPP: advanced oxidation protein products
TG: triglycerides
CL: cholesterol
CRP: C‐reactive protein
TNF‐α: tumour necrosis factor‐α
IL: interleukin
*, **: p<0.05, p<0.01 versus controls